Research News and Research

RSS

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Depomed, Inc. today announced top-line results from a Phase 3 clinical trial demonstrating DM-1796 (also referred to as gabapentin ER) achieved a statistically significant reduction in pain associated with postherpetic neuralgia (PHN) versus placebo using the baseline observation carried forward (BOCF) method required by FDA.

5 Oct 2009

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.

5 Oct 2009

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

NOAA has awarded $457,000 in competitive grant funding to support three projects to better track and manage outbreaks of toxic red tide algae that threaten public health and New England's shellfish industry. The grant covers the first year of what will be multi-year projects. Anticipated to cost almost $1.5 million over the next three years, they will be carried out by the Woods Hole Oceanographic Institution, the University of Maine and the University of Texas.

5 Oct 2009

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

To help draw attention to National Child Health Day (today), the Preventive Cardiovascular Nurses Association (PCNA) has released findings from a new national consumer survey and launched a campaign to educate families about heart disease, the leading cause of death in the U.S.

5 Oct 2009

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

5 Oct 2009

Genentech is again the world's most respected biopharmaceutical employer

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

5 Oct 2009

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Organ transplant recipients benefit significantly when they are monitored and receive prompt diagnosis and treatment for otitis media, a common inner ear infection.

5 Oct 2009

Autistic patients have underlying medical disorders that are amenable to treatment

The National Children's Health Survey published results from a 2007 telephone survey in Pediatrics today in which 78,000 households in the US were asked if their child (ages 2-17) was known to "currently have autism, Asperger's Disorder, pervasive development disorder, or other autism spectrum disorder." The survey showed that 1% of children (one in 100) now have the disorder. Previous estimates from the CDC had reported a prevalence rate of one in 150.

5 Oct 2009

Oral Cancer Foundation initiates program to donate VELscope screening systems

The Oral Cancer Foundation recently initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics and others located in, and helping communities with, underserved populations.

5 Oct 2009

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Thousands of Canadian women with metastatic breast cancer and their loved ones are marking the first Canadian Metastatic Breast Cancer Awareness Day on October 13, urging Canadians to acknowledge them and delivering the message that "hope changes."

5 Oct 2009

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

Research study on facial esthetics

Standard ideals of facial beauty and harmony may differ depending on geographic location, with a specific difference between North American beauty ideals and those of Brazilians.

5 Oct 2009

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Once relegated primarily to the domain of yogurt and high-fiber fare, the market for food and beverage products fortified with probiotics and prebiotics has taken off as digestive health emerged as one of the hottest topics in the food and beverage arena.

5 Oct 2009

Multiple Sclerosis Association of America receives National Health Information Awards

The Multiple Sclerosis Association of America (MSAA) received four communications awards, which included two APEX Awards and two National Health Information Awards.

5 Oct 2009

Preterm birth rate continues to rise

More than one million infants die each year because they are born too early, according to the just released White Paper, The Global and Regional Toll of Preterm Birth.

5 Oct 2009

Challenges in patient recruitment for clinical studies

Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.

5 Oct 2009

JCA-Mauvernay Award presented to Dr Toshikazu Ushijima for his research in oncology

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and the Japanese Cancer Association (JCA) presented 'The JCA-Mauvernay Award' to Dr Toshikazu Ushijima from the National Cancer Center Research Institute in Tokyo, for his outstanding and innovative research in basic science in the "epigenetic field for cancerization".

5 Oct 2009

Second round of revised quality standards for blood thinner heparin released

Further helping to secure public health, a second round of revised quality standards for the widely used blood thinner heparin became effective today, the U.S. Pharmacopeial (USP) Convention announced. Working closely with the Food and Drug Administration (FDA), the pharmaceutical industry, and other regulatory and scientific bodies, USP started initial revisions in 2008 after adverse reactions and deaths resulted from heparin intentionally adulterated with over-sulfated chondroitin sulfate (OSCS).

5 Oct 2009

Lawmakers urged to defend adequate Medicare funding to protect most vulnerable constituents' care

As October 1, 2009 signals the beginning of the new fiscal year 2010, the American Health Care Association (AHCA) said cuts of up to $16 billion over ten years to Medicare funded nursing home care being put into effect today by the Centers for Medicare and Medicaid Services (CMS) must be taken into account by U.S. Senate and House leaders as they continue to refine the financing details of their respective health care reform bills.

5 Oct 2009

Research News and Research

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Theraclone and Zenyaku Kogyo sign multi-year research and development agreement

NOAA awards $457,000 grant to track and manage outbreaks of toxic red tide algae

Survey finds majority of Americans are at risk of heart disease due to their lifestyle factor

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

Genentech is again the world's most respected biopharmaceutical employer

Prompt diagnosis and treatment for otitis media benefits organ transplant recipients

Autistic patients have underlying medical disorders that are amenable to treatment

Oral Cancer Foundation initiates program to donate VELscope screening systems

Willow Breast Cancer Support Canada calls for national Metastatic Breast Cancer Awareness Day

Research confirms that probiotic bacteria promotes health and boosts immune system

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Research study on facial esthetics

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Multiple Sclerosis Association of America receives National Health Information Awards

Preterm birth rate continues to rise

Challenges in patient recruitment for clinical studies

JCA-Mauvernay Award presented to Dr Toshikazu Ushijima for his research in oncology

Second round of revised quality standards for blood thinner heparin released

Lawmakers urged to defend adequate Medicare funding to protect most vulnerable constituents' care

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News